FDA Strengthens REMS for Transmucosal Immediate-Release Fentanyl Products
While the use of TIRF medications has declined in recent years, data have suggested that prescribing of these drugs to patients who are not opioid tolerant still remains.
Opioid-Related Disorder
Psychosocial Factors Are Key to Chronic Pain and Opioid Outcomes
Researchers found a relationship between pain-related anxiety with pain intensity, interference, and the potential for opioid overuse.
Machine Learning Algorithm May Diagnose Opioid Use Disorder Months Before Physicians
As the diagnosis of opioid use disorder is often delayed or missed altogether, the researchers sought to test the utility of machine learning in creating a prediction model and algorithm for early diagnosis of OUD.
Gaps Found in Opioid Use Disorder Treatment During Pandemic
Patients already receiving opioid use disorder treatment continued to receive care during the early weeks of the COVID-19 pandemic, with some disruption to urine testing.
Buprenorphine Prescription Fills for OUD Plateau During Pandemic
The number of individuals filling buprenorphine prescriptions for opioid use disorder has plateaued but not decreased during the COVID-19 pandemic.
Outpatient Buprenorphine Dispensing Up During COVID-19
In the early days of the COVID-19 pandemic, there was an increase in the number of patients receiving an outpatient buprenorphine prescription in Texas.
Little Change Seen in Prescription of Opioids for Those at Risk for Misuse
Schedule II opioids continue to be prescribed to high-risk patients 18 months after publication of the US Centers for Disease Control and Prevention guideline.
Opioids and Psychotropic Medication Frequently Coprescribed During Pregnancy
Opioid coprescription with psychotropic medications during pregnancy increases a woman’s antepartum hospitalization risk.
Youth Opioid Deaths Often Involve Other Substances, Too
In 2018, polysubstance-involved opioid overdose deaths became more common than deaths involving opioids alone among US youth.
Individuals With Major Depressive Disorder May Have a Genetic Liability Which Increases Risk for Opioid Use
This study addresses the question of whether prescription opioid medications has a potentially causal role in the risk for depression and anxiety disorder.
-
Loading...
-
Loading...
Next post in Depressive Disorder
